Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECSC.L Regulatory News (ECSC)

  • There is currently no data for ECSC

Form 8 (OPD) ECSC Group plc - Replacement

14 Apr 2023 15:49

RNS Number : 3161W
ECSC Group PLC
14 April 2023
 

The 'Form 8 (OPD) ECSC Group plc' announcement released on 14 April 2023 at 7.00 a.m. under RNS No 1895W has been reformatted.

 

All material details remain unchanged.

 

The full text is shown below.

 

 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

ECSC Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

ECSC Group plc

(d) Is the discloser the offeror or the offeree?

Offeree

(e) Date position held:

The latest practicable date prior to the disclosure

13 April 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Nil

Details, including nature of the rights concerned and relevant percentages:

Nil

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

(A) Ordinary shares of 1 pence each ("Ordinary Shares") held by directors of ECSC Group plc and their close relatives and related trusts (excluding the options and awards set out below):

 

 

Name

Number of Ordinary Shares held

% of Ordinary Shares held

Ian Mann

2,388,756

23.86%

Karen Shore

107,118

1.07%

Linda Brown

24,150

0.24%

Lauren Brown

9,345

0.09%

Max Brown

9,345

0.09%

Lucy Sharp

250,807

2.50%

Pauline Allison

4,254

0.04%

David Mathewson

35,419

0.35%

Gemma Basharan

11,562

0.11%

Christopher James

1,000

0.01%

 

Options held by directors of ECSC Group plc in ECSC Group plc shares

 

 

Name

Granted

Number of options over Ordinary Shares held

Exercise price

Vest date

Expiry date

Ian Mann

28/09/2020

100,000

£0.69

28/09/2024

27/09/2030

Lucy Sharp

21/08/2020

144,758

£0.65

21/08/2020

20/08/2030

Lucy Sharp

28/09/2020

100,000

£0.69

28/09/2024

27/09/2030

David Mathewson

18/04/2018

100,000

£0.79

18/04/2021

17/05/2028

Gemma Basharan

21/08/2020

64,651

£0.65

21/08/2020

20/08/2030

Gemma Basharan

28/09/2020

80,000

£0.69

28/09/2024

27/09/2030

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

14 April 2023

Contact name:

Gemma Basharan

Telephone number:

+44 (0) 1274 736 223

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEZZLFFXZLZBBE
Date   Source Headline
27th May 20217:00 amRNSNotice of AGM
29th Mar 20217:00 amRNSDirector/PDMR Shareholding
24th Mar 20217:00 amRNSFinal Results for the Year Ended 31 December 2020
11th Mar 20217:00 amRNSCorporate Video
1st Mar 20217:00 amRNSInvestor Presentation
22nd Feb 20217:00 amRNSNotice of Results
17th Feb 20217:00 amRNSMajor Contract Wins for MDR Division
8th Feb 20217:00 amRNSECSC announces additional webinars for February
21st Jan 20217:00 amRNSTrading Update
13th Jan 20217:00 amRNSECSC announces new webinar events for Q1 2021
8th Dec 20207:00 amRNSDirector/PDMR Shareholding
24th Nov 202012:52 pmRNSDirector/PDMR Shareholding
4th Nov 20207:00 amRNSTrading Update
27th Oct 20207:00 amRNSMajor Contract Wins for MDR Division
2nd Oct 20207:00 amRNSDirector/PDMR Shareholding
28th Sep 20201:14 pmRNSGrant of options
23rd Sep 20207:00 amRNSInterim Results
21st Sep 20207:00 amRNSInvestor Presentation
28th Aug 202011:05 amRNSSecond Price Monitoring Extn
28th Aug 202011:00 amRNSPrice Monitoring Extension
24th Aug 20207:00 amRNSCancellation and Grant of options
5th Aug 20207:00 amRNSTrading Update
1st Jul 202012:00 pmRNSDirector/PDMR Shareholding
30th Jun 20204:29 pmRNSResult of Annual General Meeting
30th Jun 20207:00 amRNSAGM Statement
1st Jun 20207:00 amRNSFinal Results and Notice of AGM
29th May 20205:00 pmRNSTotal Voting Rights
27th May 20207:00 amRNSNebula Cloud Service Launch & Coronavirus Update
5th May 20203:00 pmRNSTotal Voting Rights and Directors’ Shareholdings
5th May 202011:47 amRNSHolding(s) in Company
17th Apr 20207:00 amRNSPlacing to raise £0.5 million
25th Mar 20207:01 amRNSBoard changes
25th Mar 20207:00 amRNSFinal results for the year ended 31 December 2019
12th Mar 20207:00 amRNSManaged Services Major Contract Wins
27th Feb 20207:00 amRNSNotice of Results
5th Feb 20205:23 pmRNSGrant of EMI Options and PDMR Disclosure
28th Jan 20207:00 amRNSECSC wins industry excellence award
23rd Jan 20207:00 amRNSTrading Update
9th Jan 20207:00 amRNSManaged Services & Consulting Major Contract Wins
19th Nov 20197:00 amRNSTrading Update
11th Sep 201910:50 amRNSReplacement: Interim Results
11th Sep 20197:00 amRNSInterim Results
19th Aug 20197:00 amRNSNotice of Results
29th Jul 20196:15 pmRNSDirector/PDMR Shareholding
16th Jul 20194:28 pmRNSGrant of EMI Options and PDMR Disclosure
19th Jun 20195:30 pmRNSResult of AGM
19th Jun 20197:00 amRNSAGM Statement
20th May 20197:00 amRNSPosting of Annual Report and Notice of AGM
16th Apr 20197:00 amRNSManaged Services Contract Wins
13th Mar 20197:00 amRNSFinal Results for the year ended 31 December 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.